share_log
Benzinga ·  May 9 07:33
Intellia Therapeutics' Q1 Cash, Cash Equivalents And Marketable Securities Were $953.4M Expected To Provide Cash Runway Into Late 2026
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment